<DOC>
	<DOCNO>NCT00003683</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one chemotherapy drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine doxorubicin ifosfamide treat patient metastatic kidney cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Metastatic Kidney Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy term objective response treatment ifosfamide doxorubicin patient metastatic sarcomatoid renal cell cancer . II . Determine toxicity regimen patient . III . Determine effect regimen survival patient . OUTLINE : This multicenter study . Patients receive doxorubicin IV day 1 ifosfamide IV 2 hour day 1 2 . Treatment repeat every 3 week 8 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 20-40 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven metastatic , sarcomatoid renal cell carcinoma Measurable disease At least 15 mm pulmonary site At least 20 mm sit No uncontrolled CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 02 Life expectancy : Greater 3 month Hematopoietic : Neutrophil count great 1500/mm3 Platelet count great 100,000/mm3 Hemoglobin great 9 g/dL Hepatic : Bilirubin le 1.5 time normal Transaminases le 2 time normal ( less 4 time normal due liver metastasis ) Renal : Creatinine le 1.6 mg/dL Creatinine clearance great 60 mL/min Other : No contraindication anthracycline treatment No unstable major organ defect No prior malignancy except basal cell skin cancer carcinoma situ uterus Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2002</verification_date>
	<keyword>stage IV renal cell cancer</keyword>
</DOC>